HomeContact UsSite Map
Alkermes plc
About Us
About Us
About Alkermes
Our CompanyMessage from the CEO
Leadership
Management TeamBoard of Directors
Collaborations
Strategic Partners
Other Information
Locations
Products
Products
Our Products
Products Overview
Key Products
United StatesEuropean Union
Research & Development
Research & Development
Research & Development
R&D OverviewOur R&D ApproachPipelineTechnology PlatformsManufacturing
Other Information
Clinical TrialsMedical Education Grants
Contract Services
Contract Services
Contract Services
Why Work With Us?Our Promise to Our PartnersOur Partners
Capabilities
Capabilities OverviewRange of ServicesPublications
Investors
Investors
Investors
Corporate OverviewPress ReleasesInvestor EventsStock InformationSEC FilingsAnnual Reports
Financials
SnapshotTrading Statistics
Other Information
Email Alerts
News & Events
News & Events
News & Events
Press ReleasesCompany EventsMedia Kit
Careers
Careers
Careers
Working At AlkermesMeet Alkermes EmployeesSearch JobsBenefitsEmployee FAQs

Investors

HomeInvestorsFinancials - Snapshot

Investors

Corporate Overview Press Releases Investor Events Stock Information SEC Filings Annual Reports

Financials

Snapshot Trading Statistics

Other Information

Email Alerts

Financials - Snapshot

Print Page Print Page        E-mail Page Email Page        RSS Feeds RSS        E-mail Alerts Email Alerts        Financial Tear Sheet Tear Sheet
Revenue & Earnings
Revenue (FY)575.55
EBIT (Mil) (FY)97.46
EBITDA (Mil) (FY)171.21
Net Income Excluding Extraordinary Items (Mil) (FY)24.98
Net Income Including Extraordinary Items (Mil) (FY)24.98
Diluted EPS Excluding Extraordinary Items (FY).18
Diluted EPS Including Extraordinary Items (FY).18
Dividends
Yield (%)--
Dividend Record Date--
Dividend Rate--
Ratios
Price to Revenue (TTM)6.76
Price To Cash Flow (TTM)39.40
Price to Book (MRQ)4.04
Total Debt to Equity (MRQ) (%)38.75
Current Ratio (MRQ)4.75
Growth
5-Year Annual Dividend Growth Rate (%)--
5-Year Annual Revenue Growth Rate (%)19.05
FY = Fiscal Year MRQ = Most Recent Quarter
mil = Millions TTM = Trailing Twelve Months
Data Provided by Thomson Reuters

You are now leaving Alkermes.com.

OkayGo Back

About AlkermesOur CompanyMessage from the CEOManagement TeamBoard of DirectorsStrategic PartnersLocations
Our ProductsProducts OverviewKey U.S. ProductsKey EU Products
Research & DevelopmentR&D OverviewOur R&D ApproachPipelineTechnology PlatformsManufacturingClinical TrialsMedical Education Grants
Contract ServicesWhy Work With Us?Our Promise to Our PartnersOur PartnersCapabilities OverviewRange of ServicesPublications
InvestorsCorporate OverviewPress ReleasesInvestor RelationsStock InformationSEC FilingsAnnual ReportsFinancials SnapshotEmail Alerts
News & EventsPress ReleasesCompany EventsMedia Kit
CareersWorking at AlkermesMeet Alkermes EmployeesSearch JobsBenefitsEmployee FAQs
©2013 Alkermes. All Rights ReservedTerms of UsePrivacy Policy